Table 2 Indications for surgery by type of hysterectomy.
From: Hysterectomy at a Canadian tertiary care facility: results of a one year retrospective review
Indication | Abdominal | Vaginal | Lap-Assisted Vaginal | Vaginal Converted to Abdominal | Total (Row Percent) | Percent of Overall Total |
|---|---|---|---|---|---|---|
Dysfunctional or Abnormal Uterine Bleeding | 95 (68.3) | 31 (22.3) | 7 (5.1) | 6 (4.3) | 139 (100) | 26.4% |
Leiomyomas | 80 (95.2) | 3 (3.6) | 0 | 1 (1.2) | 84 (100) | 16.0% |
Adnexal or Pelvic Mass, Ovarian Neoplasm or Cyst | 60 (100) | 0 | 0 | 0 | 60 (100) | 11.4% |
Endometrial, Ovarian or Cervical Cancer | 54 (93.1) | 3 (5.2) | 0 | 1 (1.7) | 58 (100) | 11.0% |
Chronic Pelvic Pain, Severe Menstrual Related Mood Disorder or Dysmenorrhea | 38 (67.9) | 4 (7.1) | 13 (23.2) | 1 (1.8) | 56 (100) | 10.6% |
Endometrial Hyperplasia, Cervical Dysplasia, or Family or Personal History of Cancer | 37 (78.7) | 3 (6.4) | 6 (12.8) | 1 (2.1) | 47 (100) | 8.9% |
Pelvic Organ Prolapse or Genuine Stress Incontinence | 22 (55.0) | 15 (37.5) | 2 (5.0) | 1 (2.5) | 40 (100) | 7.6% |
Endometriosis or Adenomyosis | 22 (81.5) | 0 | 4 (14.8) | 1 (3.7) | 27 (100) | 5.1% |
Chronic Salpingitis, Oophoritis, Hydrosalpinx, Pyosalpinx, Post Menopausal Bleed or Other | 15 (100) | 0 | 0 | 0 | 15 (100) | 2.9% |
Total | 423 (80.4) | 59 (11.2) | 32 (6.1) | 12 (2.3) | 526 (100) | 100% |